Blog / Archives
Nasty Day, Nasty Month, Nasty News: Cliches Rule
All major indices and sectors sold off today making it 7 bad days out of 8 and a 6.37% correction in the S&P 500 over 30 days. The NASDAQ is now down 7.94% since May 11. Remember "sell in May...
Biotech Stocks Go Green Except Vertex (VRTX)
The market rallied on the seventh day after six days of losses but we still have a few hours to go. The Dow is up 0.96% and the NAZ is up 0.64%.Life Science stocks are strong overall with mid-caps...
June Gloom Continues : ASCO Buzz is Off But VRUS Soars
Stocks Down for Sixth Straight Session: Biotechs still up Over 10% YTD As we wind down from ASCO news with few catalysts ahead, investors and traders will regroup and rebalance their portfolios....
ASCO Stock and News Update: ARIA, BMY, EXEL, XBI
Biopharmaceutical stocks got a boost today from a rally in NASDAQ stocks and some positive news on cancer drugs from ASCO. The IBB ($106.36) was up 1.6% off its YTD and all time high of $110 and a...
Random Items: CELG Investor Network, NFLX CEO Challenges Short Seller
Celgene (CELG $58.49) is off 0.93% and down 1.29% YTD in a biotech bull market. The stock is also off 20% from 2007 and 2008 highs near $75.The Company recently bought Abraxis for $3B + and...
Rayno Life Science Portfolio:Risk is Off-EXEL,GPRO,UTHR
Speculation in small cap biopharmaceutical stocks has peaked and we urged weeks ago to raise cash positions to 10-15%. The ASCO "sell on the news effect" has continued today with some high fliers...
Broad Market Sell-Off After Weak Jobs Data: Indices Off Almost 1% -Update
Even the Market is Bored with Economic Data-It's All About Jobs Weak U.S. payrolls data with a rise of only 54,000 jobs push jobless rate up to 9.1% reversing April's advance. This mirrors recent...
New Moon and June Gloom: Macro Rules, Risk Off
Market Sell-Off Over 2%-Worse Day Since August 2010 Yesterday's rally was obviously a good hangover from your Memorial Day weekend. The bad economic news has finally come to roost and the selling...
Energy,Technology and Healthcare Sectors Pace Gains Today
Despite the continuing gloomy backdrop of a Greece default, U.S, debt ceiling and weak housing data, several market sectors rallied today. The NASDAQ was the leader up 1.37% and the S&P was up...
Rayno Life Science Portfolio: AMRI, GILD, NKTR, OPTR all up
The life science market continued to show resilience today with a few big movers and a bidding up of large cap drugs such as Johnson and Johnson (JNJ $67.15), Novartis (NVS $64.24), Pfizer(PFE...